Bioventix Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Bioventix.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 34.5% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 28 Oct 2024 |
Recent future growth updates
Recent updates
Estimating The Fair Value Of Bioventix PLC (LON:BVXP)
Jun 19Bioventix's (LON:BVXP) Dividend Will Be £0.68
Mar 29We Think Shareholders May Consider Being More Generous With Bioventix PLC's (LON:BVXP) CEO Compensation Package
Dec 01Bioventix (LON:BVXP) Is Increasing Its Dividend To £0.62
Mar 30Bioventix (LON:BVXP) Is Increasing Its Dividend To UK£0.52
Mar 31Should Bioventix PLC (LON:BVXP) Be Part Of Your Dividend Portfolio?
Mar 29Is Now The Time To Put Bioventix (LON:BVXP) On Your Watchlist?
Mar 14What Does Bioventix's (LON:BVXP) CEO Pay Reveal?
Feb 27Shareholders of Bioventix (LON:BVXP) Must Be Delighted With Their 364% Total Return
Jan 31Is Bioventix PLC (LON:BVXP) Popular Amongst Insiders?
Jan 18Is Bioventix PLC's (LON:BVXP) Latest Stock Performance Being Led By Its Strong Fundamentals?
Jan 06Here's How We Evaluate Bioventix PLC's (LON:BVXP) Dividend
Dec 23Does Bioventix's (LON:BVXP) CEO Salary Compare Well With Industry Peers?
Nov 28Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2025 | 15 | 9 | 8 | 11 | 1 |
6/30/2024 | 14 | 8 | 8 | 8 | N/A |
3/31/2024 | 14 | 8 | 8 | 8 | N/A |
12/31/2023 | 14 | 9 | 8 | 8 | N/A |
9/30/2023 | 13 | 9 | 8 | 8 | N/A |
6/30/2023 | 13 | 8 | 8 | 8 | N/A |
3/31/2023 | 13 | 8 | 8 | 8 | N/A |
12/31/2022 | 13 | 8 | 8 | 8 | N/A |
9/30/2022 | 12 | 8 | 8 | 8 | N/A |
6/30/2022 | 12 | 8 | 8 | 8 | N/A |
3/31/2022 | 11 | 7 | 7 | 7 | N/A |
12/31/2021 | 10 | 7 | 7 | 7 | N/A |
9/30/2021 | 11 | 7 | 6 | 7 | N/A |
6/30/2021 | 11 | 7 | 6 | 6 | N/A |
3/31/2021 | 11 | 7 | 6 | 7 | N/A |
12/31/2020 | 10 | 7 | 7 | 7 | N/A |
9/30/2020 | 10 | 7 | 7 | 7 | N/A |
6/30/2020 | 10 | 7 | 7 | 8 | N/A |
3/31/2020 | 10 | 7 | 7 | 7 | N/A |
12/31/2019 | 10 | 7 | 6 | 7 | N/A |
9/30/2019 | 10 | 6 | 6 | 6 | N/A |
6/30/2019 | 9 | 6 | 6 | 6 | N/A |
3/31/2019 | 9 | 6 | 6 | 6 | N/A |
12/31/2018 | 9 | 6 | 6 | 6 | N/A |
9/30/2018 | 9 | 6 | 6 | 6 | N/A |
6/30/2018 | 9 | 6 | 6 | 6 | N/A |
3/31/2018 | 9 | 6 | N/A | 5 | N/A |
12/31/2017 | 8 | 6 | N/A | 5 | N/A |
9/30/2017 | 8 | 5 | N/A | 4 | N/A |
6/30/2017 | 7 | 5 | N/A | 4 | N/A |
3/31/2017 | 7 | 5 | N/A | 4 | N/A |
12/31/2016 | 6 | 4 | N/A | 4 | N/A |
9/30/2016 | 6 | 4 | N/A | 3 | N/A |
6/30/2016 | 6 | 3 | N/A | 3 | N/A |
3/31/2016 | 5 | 3 | N/A | 3 | N/A |
12/31/2015 | 5 | 3 | N/A | 2 | N/A |
9/30/2015 | 5 | 3 | N/A | 2 | N/A |
6/30/2015 | 4 | 3 | N/A | 2 | N/A |
3/31/2015 | 4 | 2 | N/A | 2 | N/A |
12/31/2014 | 4 | 2 | N/A | 2 | N/A |
9/30/2014 | 4 | 2 | N/A | 2 | N/A |
6/30/2014 | 4 | 2 | N/A | 2 | N/A |
3/31/2014 | 3 | 2 | N/A | 2 | N/A |
12/31/2013 | 3 | 2 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BVXP's forecast earnings growth is above the savings rate (2.1%).
Earnings vs Market: Insufficient data to determine if BVXP's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if BVXP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BVXP's revenue is forecast to grow faster than the UK market.
High Growth Revenue: Insufficient data to determine if BVXP's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BVXP's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 01:39 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bioventix PLC is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Buxton | Cavendish |
null null | Cavendish |
Adam McCarter | Cavendish |